Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emily C Zabor

Showing results (1-10 of 167) with videos related to

Pageof 17
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 28, 2026
Propensity Score-Matched External Controls in Rare Disease Trials: A Promising Tool Requiring Rigorous ValidationEmily C Zabor
Ocular Oncology and Pathology|April 2, 2021
Comment on "Age Conditional Probability of Ocular and Ocular Adnexal Malignancies"Emily C Zabor
Annals of Surgical Oncology|November 3, 2018
ASO Author Reflections: Careful Development and Thoughtful Interpretation are Needed when Developing Online Prognostic ToolsEmily C Zabor
The Journal of Urology|April 10, 2023
On the Need for Landmark Analysis or Time-dependent CovariatesEmily C Zabor, Melissa Assel
Statistics in Medicine|January 19, 2022
Analysis of composite endpoints with component-wise censoring in the presence of differential visit schedulesAnne A Eaton, Emily C Zabor
Statistics in Medicine|July 28, 2017
A comparison of statistical methods for the study of etiologic heterogeneityEmily C Zabor, Colin B Begg
American Journal of Epidemiology|August 28, 2012
Detecting and exploiting etiologic heterogeneity in epidemiologic studiesColin B Begg, Emily C Zabor
Plos One|May 18, 2021
Uveal melanoma: Long-term survivalTomas Radivoyevitch, Emily C Zabor, Arun D Singh
JAMA Ophthalmology|October 16, 2025
Unifying Diagnosis of Choroidal Indeterminate Melanocytic Tumors-ReplyArun D Singh, Yehonatan Weinberger, Emily C Zabor
The Breast Journal|March 6, 2013
Response to the "letter to the editor" by Dr. Thomas FilleronChaya S Moskowitz, Emily C Zabor, Maxine Jochelson
Pageof 17

Showing results (1-10 of 167) with videos related to

Sort By:
Pageof 17
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 28, 2026
Propensity Score-Matched External Controls in Rare Disease Trials: A Promising Tool Requiring Rigorous ValidationEmily C Zabor
Ocular Oncology and Pathology|April 2, 2021
Comment on "Age Conditional Probability of Ocular and Ocular Adnexal Malignancies"Emily C Zabor
Annals of Surgical Oncology|November 3, 2018
ASO Author Reflections: Careful Development and Thoughtful Interpretation are Needed when Developing Online Prognostic ToolsEmily C Zabor
The Journal of Urology|April 10, 2023
On the Need for Landmark Analysis or Time-dependent CovariatesEmily C Zabor, Melissa Assel
Statistics in Medicine|January 19, 2022
Analysis of composite endpoints with component-wise censoring in the presence of differential visit schedulesAnne A Eaton, Emily C Zabor
Statistics in Medicine|July 28, 2017
A comparison of statistical methods for the study of etiologic heterogeneityEmily C Zabor, Colin B Begg
American Journal of Epidemiology|August 28, 2012
Detecting and exploiting etiologic heterogeneity in epidemiologic studiesColin B Begg, Emily C Zabor
Plos One|May 18, 2021
Uveal melanoma: Long-term survivalTomas Radivoyevitch, Emily C Zabor, Arun D Singh
JAMA Ophthalmology|October 16, 2025
Unifying Diagnosis of Choroidal Indeterminate Melanocytic Tumors-ReplyArun D Singh, Yehonatan Weinberger, Emily C Zabor
The Breast Journal|March 6, 2013
Response to the "letter to the editor" by Dr. Thomas FilleronChaya S Moskowitz, Emily C Zabor, Maxine Jochelson
Pageof 17